| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA-Binding Proteins | 26 | 2025 | 578 | 6.120 |
Why?
|
| RNA | 12 | 2024 | 574 | 1.750 |
Why?
|
| Immunoprecipitation | 8 | 2022 | 199 | 1.740 |
Why?
|
| Binding Sites | 14 | 2022 | 1305 | 1.320 |
Why?
|
| Caenorhabditis elegans | 5 | 2016 | 227 | 1.260 |
Why?
|
| Transcriptome | 7 | 2024 | 977 | 1.100 |
Why?
|
| Gene Library | 2 | 2017 | 218 | 1.020 |
Why?
|
| Gene Expression Profiling | 10 | 2020 | 1756 | 0.970 |
Why?
|
| RNA, Ribosomal | 3 | 2025 | 63 | 0.960 |
Why?
|
| RNA, Small Nucleolar | 1 | 2025 | 13 | 0.940 |
Why?
|
| Sequence Analysis, RNA | 6 | 2019 | 371 | 0.860 |
Why?
|
| Computational Biology | 6 | 2019 | 819 | 0.810 |
Why?
|
| Cross-Linking Reagents | 3 | 2017 | 55 | 0.780 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2020 | 80 | 0.770 |
Why?
|
| Caenorhabditis elegans Proteins | 5 | 2016 | 89 | 0.720 |
Why?
|
| Chromatin | 5 | 2020 | 579 | 0.700 |
Why?
|
| RNA Splicing | 8 | 2024 | 229 | 0.700 |
Why?
|
| Gene Regulatory Networks | 3 | 2013 | 363 | 0.670 |
Why?
|
| Alternative Splicing | 8 | 2023 | 355 | 0.660 |
Why?
|
| Protein Binding | 12 | 2024 | 1755 | 0.640 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2022 | 887 | 0.580 |
Why?
|
| Reverse Transcription | 1 | 2017 | 4 | 0.570 |
Why?
|
| Gene Expression Regulation | 8 | 2020 | 2524 | 0.550 |
Why?
|
| DNA | 3 | 2024 | 1619 | 0.540 |
Why?
|
| CRISPR-Cas Systems | 3 | 2021 | 256 | 0.520 |
Why?
|
| Staining and Labeling | 1 | 2016 | 184 | 0.510 |
Why?
|
| K562 Cells | 5 | 2020 | 95 | 0.500 |
Why?
|
| RNA, Messenger | 9 | 2024 | 2812 | 0.500 |
Why?
|
| Introns | 4 | 2024 | 300 | 0.470 |
Why?
|
| Genome, Helminth | 2 | 2011 | 10 | 0.470 |
Why?
|
| Nuclear Proteins | 3 | 2017 | 1284 | 0.460 |
Why?
|
| Spliceosomes | 3 | 2025 | 54 | 0.430 |
Why?
|
| Base Sequence | 8 | 2020 | 3109 | 0.420 |
Why?
|
| Hep G2 Cells | 5 | 2023 | 86 | 0.420 |
Why?
|
| Homeodomain Proteins | 2 | 2013 | 556 | 0.410 |
Why?
|
| RNA, Double-Stranded | 2 | 2024 | 63 | 0.400 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2024 | 520 | 0.400 |
Why?
|
| Databases, Genetic | 3 | 2020 | 475 | 0.390 |
Why?
|
| Molecular Sequence Annotation | 3 | 2020 | 148 | 0.370 |
Why?
|
| Adenosine Deaminase | 3 | 2021 | 89 | 0.370 |
Why?
|
| Longevity | 1 | 2013 | 135 | 0.370 |
Why?
|
| RNA, Small Nuclear | 2 | 2025 | 49 | 0.370 |
Why?
|
| RNA Editing | 3 | 2021 | 34 | 0.350 |
Why?
|
| Animals | 22 | 2025 | 34309 | 0.310 |
Why?
|
| Transcription Factors | 4 | 2013 | 2603 | 0.310 |
Why?
|
| Gene Knockdown Techniques | 3 | 2020 | 367 | 0.290 |
Why?
|
| Humans | 37 | 2025 | 125438 | 0.270 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 1006 | 0.270 |
Why?
|
| Cell Line | 4 | 2020 | 2755 | 0.260 |
Why?
|
| Protein Isoforms | 2 | 2018 | 404 | 0.230 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2024 | 21 | 0.230 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group M | 1 | 2024 | 3 | 0.230 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2024 | 32 | 0.230 |
Why?
|
| Aging | 4 | 2016 | 1182 | 0.220 |
Why?
|
| RNA Polymerase II | 1 | 2024 | 100 | 0.220 |
Why?
|
| RNA Splice Sites | 3 | 2024 | 90 | 0.220 |
Why?
|
| HEK293 Cells | 4 | 2024 | 739 | 0.220 |
Why?
|
| 3' Untranslated Regions | 4 | 2019 | 164 | 0.220 |
Why?
|
| Mice | 13 | 2025 | 17744 | 0.220 |
Why?
|
| Nucleic Acid Conformation | 3 | 2024 | 185 | 0.210 |
Why?
|
| Organ Specificity | 3 | 2013 | 426 | 0.210 |
Why?
|
| Nucleotide Motifs | 4 | 2018 | 43 | 0.210 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2023 | 47 | 0.200 |
Why?
|
| Exons | 5 | 2024 | 801 | 0.200 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 2 | 2020 | 68 | 0.200 |
Why?
|
| Optical Imaging | 1 | 2023 | 66 | 0.200 |
Why?
|
| Genomics | 3 | 2020 | 1520 | 0.190 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group C | 1 | 2021 | 1 | 0.190 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2020 | 161 | 0.190 |
Why?
|
| Interferon Type I | 1 | 2021 | 107 | 0.180 |
Why?
|
| MicroRNAs | 2 | 2022 | 855 | 0.180 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2020 | 12 | 0.180 |
Why?
|
| Genome | 2 | 2020 | 481 | 0.170 |
Why?
|
| Intracellular Space | 1 | 2020 | 49 | 0.170 |
Why?
|
| Blast Crisis | 1 | 2020 | 16 | 0.170 |
Why?
|
| Retroelements | 1 | 2020 | 41 | 0.170 |
Why?
|
| Tissue Array Analysis | 1 | 2020 | 137 | 0.170 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2023 | 746 | 0.170 |
Why?
|
| Genetic Variation | 2 | 2019 | 1505 | 0.170 |
Why?
|
| Antibodies | 2 | 2023 | 374 | 0.170 |
Why?
|
| Substrate Specificity | 1 | 2020 | 295 | 0.160 |
Why?
|
| Ribosome Subunits, Small | 1 | 2019 | 3 | 0.160 |
Why?
|
| RNA Precursors | 2 | 2019 | 67 | 0.160 |
Why?
|
| Ribosomal Proteins | 1 | 2019 | 71 | 0.160 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 162 | 0.160 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2020 | 369 | 0.160 |
Why?
|
| Microscopy, Confocal | 1 | 2020 | 349 | 0.150 |
Why?
|
| Ribosomes | 1 | 2019 | 137 | 0.150 |
Why?
|
| Metformin | 1 | 2020 | 150 | 0.150 |
Why?
|
| RNA Stability | 2 | 2016 | 84 | 0.150 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2019 | 151 | 0.150 |
Why?
|
| RNA Recognition Motif Proteins | 1 | 2018 | 16 | 0.150 |
Why?
|
| Repressor Proteins | 2 | 2022 | 826 | 0.150 |
Why?
|
| Glioma | 1 | 2023 | 512 | 0.150 |
Why?
|
| Databases, Factual | 1 | 2023 | 1174 | 0.140 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2017 | 57 | 0.140 |
Why?
|
| Conserved Sequence | 3 | 2010 | 291 | 0.140 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2023 | 403 | 0.140 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2017 | 100 | 0.140 |
Why?
|
| Cell Survival | 2 | 2016 | 820 | 0.140 |
Why?
|
| Alu Elements | 3 | 2024 | 65 | 0.140 |
Why?
|
| Transcription, Genetic | 5 | 2024 | 1705 | 0.140 |
Why?
|
| Exonucleases | 1 | 2017 | 23 | 0.140 |
Why?
|
| Molecular Biology | 1 | 2017 | 80 | 0.140 |
Why?
|
| Alleles | 2 | 2019 | 1617 | 0.140 |
Why?
|
| Cluster Analysis | 3 | 2013 | 405 | 0.140 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2016 | 9 | 0.130 |
Why?
|
| Software | 2 | 2018 | 687 | 0.130 |
Why?
|
| Endonucleases | 1 | 2016 | 55 | 0.130 |
Why?
|
| Protein Domains | 1 | 2017 | 236 | 0.130 |
Why?
|
| Homologous Recombination | 1 | 2016 | 93 | 0.130 |
Why?
|
| GATA Transcription Factors | 1 | 2016 | 7 | 0.130 |
Why?
|
| Photochemical Processes | 1 | 2016 | 6 | 0.130 |
Why?
|
| RNA Interference | 2 | 2020 | 508 | 0.130 |
Why?
|
| Cerebellar Diseases | 1 | 2017 | 74 | 0.130 |
Why?
|
| RNA-Binding Motifs | 1 | 2016 | 3 | 0.130 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2015 | 13 | 0.130 |
Why?
|
| Mutation | 4 | 2017 | 5903 | 0.120 |
Why?
|
| Motor Neurons | 1 | 2016 | 138 | 0.120 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 55 | 0.120 |
Why?
|
| Datasets as Topic | 1 | 2016 | 91 | 0.120 |
Why?
|
| Pluripotent Stem Cells | 1 | 2016 | 71 | 0.120 |
Why?
|
| STAT1 Transcription Factor | 1 | 2015 | 73 | 0.120 |
Why?
|
| Protein Transport | 1 | 2016 | 369 | 0.120 |
Why?
|
| Autistic Disorder | 1 | 2018 | 349 | 0.120 |
Why?
|
| Cloning, Molecular | 1 | 2016 | 898 | 0.120 |
Why?
|
| Ultraviolet Rays | 1 | 2016 | 204 | 0.120 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 149 | 0.120 |
Why?
|
| Fibroblasts | 2 | 2016 | 887 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2020 | 818 | 0.120 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 343 | 0.120 |
Why?
|
| DNA Repair | 1 | 2017 | 591 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 1980 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 1128 | 0.110 |
Why?
|
| Genome, Human | 2 | 2020 | 1293 | 0.110 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2013 | 25 | 0.110 |
Why?
|
| Protein Conformation | 1 | 2016 | 836 | 0.110 |
Why?
|
| Registries | 1 | 2020 | 1434 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 1 | 2015 | 218 | 0.110 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2013 | 9 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2015 | 462 | 0.110 |
Why?
|
| Peptides | 1 | 2016 | 812 | 0.100 |
Why?
|
| DiGeorge Syndrome | 1 | 2013 | 80 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 1587 | 0.100 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 239 | 0.100 |
Why?
|
| Models, Molecular | 1 | 2016 | 1084 | 0.100 |
Why?
|
| Cell Line, Tumor | 3 | 2024 | 3419 | 0.100 |
Why?
|
| Peptide Hormones | 1 | 2013 | 68 | 0.100 |
Why?
|
| Systems Biology | 1 | 2011 | 58 | 0.090 |
Why?
|
| Algorithms | 2 | 2016 | 1633 | 0.090 |
Why?
|
| Apoptosis | 1 | 2017 | 1817 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 360 | 0.090 |
Why?
|
| Chromosome Deletion | 1 | 2013 | 652 | 0.090 |
Why?
|
| Chromosomes | 1 | 2010 | 207 | 0.080 |
Why?
|
| RNA Splicing Factors | 2 | 2023 | 50 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2024 | 538 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2020 | 4595 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 778 | 0.070 |
Why?
|
| Evolution, Molecular | 2 | 2010 | 669 | 0.070 |
Why?
|
| Cytoplasm | 2 | 2020 | 296 | 0.070 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2007 | 16 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 736 | 0.070 |
Why?
|
| Brain | 1 | 2018 | 3012 | 0.070 |
Why?
|
| Gene Expression | 3 | 2016 | 1554 | 0.070 |
Why?
|
| Silencer Elements, Transcriptional | 1 | 2006 | 6 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2020 | 436 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2006 | 241 | 0.060 |
Why?
|
| HCT116 Cells | 1 | 2024 | 55 | 0.060 |
Why?
|
| DNA, Superhelical | 1 | 2024 | 20 | 0.060 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2024 | 63 | 0.060 |
Why?
|
| Phenotype | 1 | 2013 | 4269 | 0.060 |
Why?
|
| Interferons | 1 | 2024 | 126 | 0.050 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 2023 | 8 | 0.050 |
Why?
|
| Proteoglycans | 1 | 2023 | 88 | 0.050 |
Why?
|
| Histones | 2 | 2020 | 542 | 0.050 |
Why?
|
| Hematopoiesis | 1 | 2024 | 215 | 0.050 |
Why?
|
| Neoplasms | 1 | 2017 | 2800 | 0.050 |
Why?
|
| Cell Self Renewal | 1 | 2022 | 45 | 0.050 |
Why?
|
| THP-1 Cells | 1 | 2021 | 23 | 0.050 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2021 | 13 | 0.050 |
Why?
|
| Cytosol | 1 | 2021 | 162 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2023 | 808 | 0.040 |
Why?
|
| Inflammation | 2 | 2020 | 1447 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2021 | 222 | 0.040 |
Why?
|
| DNA Footprinting | 1 | 2020 | 14 | 0.040 |
Why?
|
| Deoxyribonuclease I | 1 | 2020 | 49 | 0.040 |
Why?
|
| DNA Replication Timing | 1 | 2020 | 11 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2020 | 149 | 0.040 |
Why?
|
| Metabolism | 1 | 2020 | 42 | 0.040 |
Why?
|
| Transposases | 1 | 2020 | 44 | 0.040 |
Why?
|
| Protein Aggregates | 1 | 2020 | 30 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2020 | 122 | 0.040 |
Why?
|
| Male | 3 | 2020 | 61626 | 0.040 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2020 | 166 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2020 | 214 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2023 | 634 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2020 | 586 | 0.040 |
Why?
|
| RNA, Small Cytoplasmic | 1 | 2019 | 2 | 0.040 |
Why?
|
| Inosine | 1 | 2019 | 11 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2022 | 376 | 0.040 |
Why?
|
| Ribonucleoproteins | 1 | 2019 | 64 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2019 | 200 | 0.040 |
Why?
|
| RNA Helicases | 1 | 2019 | 63 | 0.040 |
Why?
|
| Autoantigens | 1 | 2019 | 118 | 0.040 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2018 | 124 | 0.040 |
Why?
|
| Adenosine | 1 | 2019 | 129 | 0.040 |
Why?
|
| Disease | 1 | 2019 | 129 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 287 | 0.040 |
Why?
|
| Machine Learning | 1 | 2020 | 251 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2017 | 7 | 0.030 |
Why?
|
| D-Amino-Acid Oxidase | 1 | 2016 | 1 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 581 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2016 | 46 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 443 | 0.030 |
Why?
|
| Transfection | 1 | 2019 | 1076 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2020 | 1638 | 0.030 |
Why?
|
| Female | 2 | 2020 | 66887 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 664 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 2016 | 119 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2019 | 193 | 0.030 |
Why?
|
| Polyadenylation | 1 | 2016 | 55 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 140 | 0.030 |
Why?
|
| Human Embryonic Stem Cells | 1 | 2016 | 19 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2019 | 654 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 461 | 0.030 |
Why?
|
| Integrins | 1 | 2016 | 97 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 172 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 4420 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2016 | 347 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2017 | 260 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2019 | 801 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2017 | 420 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 2414 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2016 | 193 | 0.030 |
Why?
|
| Genotype | 1 | 2020 | 2569 | 0.030 |
Why?
|
| Zebrafish | 1 | 2017 | 380 | 0.030 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 249 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2016 | 680 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 670 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2021 | 1538 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2020 | 1051 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2016 | 429 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2015 | 421 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 818 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2015 | 505 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2020 | 1025 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 682 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 2904 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 780 | 0.020 |
Why?
|
| Intestines | 1 | 2016 | 577 | 0.020 |
Why?
|
| RNA, Helminth | 1 | 2010 | 8 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2016 | 771 | 0.020 |
Why?
|
| Genes, Helminth | 1 | 2010 | 22 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2013 | 1086 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2013 | 532 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 1271 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 1316 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2010 | 114 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 2652 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 4406 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 3310 | 0.020 |
Why?
|
| Neurons | 1 | 2018 | 1943 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 3175 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2010 | 761 | 0.020 |
Why?
|
| Expressed Sequence Tags | 1 | 2005 | 79 | 0.010 |
Why?
|
| Biological Evolution | 1 | 2005 | 227 | 0.010 |
Why?
|
| Models, Biological | 1 | 2006 | 1466 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 3043 | 0.010 |
Why?
|